Coombs M M
Mutat Res. 1982 Jan-Feb;100(1-4):403-5. doi: 10.1016/0165-1218(82)90084-2.
Groups of T.O. mice (Theiler's Original, derived from Swiss albino mice) were treated topically, with a single dose of 1.0 mg of 4CMB, 4HMB, or BC, or with 0.4 mg benzo[a]pyrene (B[a]P). Twice-weekly promotion of the treated skin area with croton oil was begun 1 week later. At 10 months the skin-tumour incidence in the positive control (B[a]P) was 8/19, with a mean latent period of 20 weeks. Both 4CMB and 4HMB have so far produced 1 papilloma each (1/36 at 40 weeks, and 1/39 at 34 weeks, respectively), while BC has produced none. Further time is required in order to ascertain whether these single papillomas will develop into carcinomas and thereby herald weak initiating activity for 4CMB and 4HMB.
将T.O.小鼠(源自瑞士白化小鼠的泰勒氏原种)分组,分别用1.0毫克的4 - 氯甲基联苯(4CMB)、4 - 羟基甲基联苯(4HMB)或苯并[c]荧蒽(BC)单剂量进行局部处理,或用0.4毫克苯并[a]芘(B[a]P)处理。1周后开始用巴豆油对处理过的皮肤区域进行每周两次的促癌处理。10个月时,阳性对照(B[a]P)组的皮肤肿瘤发生率为8/19,平均潜伏期为20周。到目前为止,4CMB和4HMB各产生了1个乳头状瘤(分别在40周时为1/36,34周时为1/39),而BC未产生肿瘤。为了确定这些单个乳头状瘤是否会发展成癌,从而预示4CMB和4HMB的弱启动活性,还需要更多时间。